Market Dynamics: The global hyperlipidemia treatment market exhibited significant strength in 2021 and is poised to experience a rapid compound annual growth rate (CAGR) in revenue over the forecast period. This growth is attributed to the expanding target population and heightened awareness of the cardiovascular disease (CVD) risks associated with persistent hyperlipidemia. However, the global […]